BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3657805)

  • 1. Regulation of human natural cytotoxicity by IgG--I. Characterization of the structural site on monomeric IgG responsible for inhibiting natural killer cell activity.
    Gherman M; Manciulea M; Bancu AC; Sulica A; Stanworth DR; Herberman RB
    Mol Immunol; 1987 Jul; 24(7):743-50. PubMed ID: 3657805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human natural cytotoxicity by IgG. IV. Association between binding of monomeric IgG to the Fc receptors on large granular lymphocytes and inhibition of natural killer (NK) cell activity.
    Sulica A; Galatiuc C; Manciulea M; Bancu AC; DeLeo A; Whiteside TL; Herberman RB
    Cell Immunol; 1993 Apr; 147(2):397-410. PubMed ID: 8453679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
    Hadley AG; Zupanska B; Kumpel BM; Leader KA
    Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human natural killer cell activity by cytophilic immunoglobulin G.
    Sulica A; Gherman M; Galatiuc C; Manciulea M; Herberman RB
    J Immunol; 1982 Mar; 128(3):1031-6. PubMed ID: 7057031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interleukin-2 on the monomeric IgG-induced inhibition of human natural killer cell activity.
    Gherman M; Herberman RB; Sulica A
    Nat Immun Cell Growth Regul; 1989; 8(5):255-65. PubMed ID: 2512481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human natural cytotoxicity by IgG. II. Cyclic AMP as a mediator of monomeric IgG-induced inhibition of natural killer cell activity.
    Bancu AC; Gherman M; Sulica A; Goto T; Farrar W; Herberman RB
    Cell Immunol; 1988 Jul; 114(2):246-56. PubMed ID: 2455604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human natural killer cell activity by polyclonal IgM.
    Manciulea M; Pricop L; Sulica A; Herberman RB
    Mol Immunol; 1989 Dec; 26(12):1087-93. PubMed ID: 2633044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of human immunoglobulin G with CD16 on natural killer cells: ligand clearance, FcgammaRIIIA turnover and effects of metalloproteinases on FcgammaRIIIA-mediated binding, signal transduction and killing.
    Mota G; Moldovan I; Calugaru A; Hirt M; Kozma E; Galatiuc C; Brasoveanu L; Boltz-Nitulescu G
    Scand J Immunol; 2004 Mar; 59(3):278-84. PubMed ID: 15030579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
    Galatiuc C; Gherman M; Metes D; Sulica A; DeLeo A; Whiteside TL; Herberman RB
    Cell Immunol; 1995 Jul; 163(2):167-77. PubMed ID: 7606790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent effects of Fc gamma RIIIA ligands on the functional activities of human natural killer cells in vitro.
    Sulica A; Metes D; Gherman M; Whiteside TL; Herberman RB
    Eur J Immunol; 1996 Jun; 26(6):1199-203. PubMed ID: 8647192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human natural cytotoxicity by IgG. III. Interaction between negative regulation by monomeric IgG and positive regulation by interferons of different types.
    Sulica A; Gherman M; Manciulea M; Galatiuc C; Herberman RB
    Nat Immun Cell Growth Regul; 1989; 8(5):266-78. PubMed ID: 2480519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of IgG and IgM receptor triggering on human natural killer cell cytotoxicity measured on the level of the single effector cell.
    Merrill JE; Ullberg M; Jondal M
    Eur J Immunol; 1981 Jul; 11(7):536-41. PubMed ID: 7286062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity against the K562 erythroleukemia cell line by human natural killer (NK) cells which do not bear free Fc receptors for IgG.
    Kay HD; Fagnani R; Bonnard GD
    Int J Cancer; 1979 Aug; 24(2):141-50. PubMed ID: 290570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
    Heiskala M; Ståhls A; Seppälä I; Timonen T
    Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region.
    Michaelsen TE; Aase A; Norderhaug L; Sandlie I
    Mol Immunol; 1992 Mar; 29(3):319-26. PubMed ID: 1557042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation.
    Lund J; Tanaka T; Takahashi N; Sarmay G; Arata Y; Jefferis R
    Mol Immunol; 1990 Nov; 27(11):1145-53. PubMed ID: 2174119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer and T-cell potentiation by monoclonal IgG against natural killer cell FcR(IgG) or the T3 complex.
    Jondal M; Kullman C; Alter MB; Ljunggren K
    Scand J Immunol; 1986 Jun; 23(6):639-45. PubMed ID: 3520802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
    Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
    Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Fc-optimized NKG2D-immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia.
    Steinbacher J; Baltz-Ghahremanpour K; Schmiedel BJ; Steinle A; Jung G; Kübler A; André MC; Grosse-Hovest L; Salih HR
    Int J Cancer; 2015 Mar; 136(5):1073-84. PubMed ID: 25046567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of natural killer cell activity by rabbit antibody to human beta 2-microglobulin (beta 2m) is an Fc-mediated phenomenon and is not beta 2m specific.
    Jones RA; Richards SJ; Patel D; Scott CS
    Immunology; 1991 Jul; 73(3):342-7. PubMed ID: 1831793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.